Your SlideShare is downloading. ×

د فيصل الناصر

131
views

Published on

د فيصل الناصر - Faisal Alnasir is a Professor and Chairman at Dept Of Family & Community Medicine at Arabian Gulf University. …

د فيصل الناصر - Faisal Alnasir is a Professor and Chairman at Dept Of Family & Community Medicine at Arabian Gulf University.
http://www.faisalalnasir.com

Published in: Health & Medicine

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
131
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Hypertension the Silent Killer Epidemiology Prof Faisal A Alnasir FRCGP, MICGP, FFPH, PhD President, Family & Community Medicine Council Arab Board Chairman, Department of Family & Community Medicine Arabian Gulf University
  • 2. 2 Hypertension • Common • Non Communicable disease • Inevitable • Preventable • Serious complication
  • 3. 3 WHO estimated that high blood pressure causes one in every eight deaths, making hypertension the third leading killer in the world. Globally, there are one billion hypertensives and four million people die annually as a direct result of it. Hussein A. Gezairy Regional Director for the Eastern Mediterranean
  • 4. 4
  • 5. 5 Size of the problem 1-World wide • In 2010, 1.2 billion people were expected to be suffering from hypertension worldwide Sixth report of the Joint National Committee on prevention,1997 • Expected to increase to 1.56 billion by 2025 International Society of Hypertension • Its prevalence from 20% to 30% of the adult population. Alwan A 1993 • Incidence In USA between 14% to 40% in 35 to 64 years. WHO 2002 • Prevalence in Canada 17.3%. Most patients had untreated hypertension (68.6%), and only 15.8% had blood pressure treated and controlled.
  • 6. 6 Size of the problem 2-In the Eastern Mediterranean Region • The average prevalence of hypertension 26% and it affects approximately 125 million individuals. • Each year, there are several million new cases of hypertension and more of pre-hypertension Report on the regional consultation on hypertension UAE, 2003
  • 7. 7 Size of the problem In Bahrain National Non-communicable Diseases Risk Factors Survey 2007
  • 8. 8 Size of the problem In Bahrain National Non-communicable Diseases Risk Factors Survey 2007
  • 9. In Lebanon •23.1% are hypertensive •Prevalence increases with age •Occurs more in the less educated and unemployed •Prevalence increases significantly with an increase in body mass index particularly in female patients •Only14.7% exercised daily R A Tohme, A R Jurjus, A Estephan 2005
  • 10. 10 Size of the problem In Saudi Arabia: The prevalence range from 4% to 15%. Abolfotouh MA et al. It may reach as high as 20.4% for systolic hypertension and 25.9% for diastolic hypertension. Al-Nozha MM et al. In south-western 11.1%. Abolfotouh MA et al. In Jeddah, the hypertensive were 22.6%. Elkalifa Am et al.2011 In the UAE: Hypertension has become one of the leading public health problems
  • 11. In Sudan  of 6-12y children: 4.9% were pre-hypertensive and 4.9% were hypertensive Salman Z, et al 2010
  • 12. 12 Size of the problem It has been estimated that individuals who are normotensive at the age 55 years have a 90% lifetime risk for developing hypertension. EMR0 Technical Publications Blood pressure is under control in less than 20% of patients with hypertension in many countries A joint CINDI/EuroPharm Forum project WHO
  • 13. 13 Awareness of Hypertension Although the prevalence of high blood pressure is high, there is a low awareness rate (Up To 70% are unaware) Alwan A1993
  • 14. Awareness of Hypertension Faisal Alnasir, 2004
  • 15. 15 Awareness of Hypertension In Egypt only 37.5% of hypertensives were aware of Having it. In United States, Chile, and Cub, 32%, 37%, and 39% of the people were not aware. Pan American Health
  • 16. 16 Advantage of Controlling Hypertension •A 5-6 mmHg reduction in diastolic BP reduces stroke by 40%. Joint National Committee on Detection, 1992 •lowering by 5-6mmHg can reduce mortality from cerebrovascular disease by 35%-40%, from ischemic heart disease by 15% 20% and reduction in all deaths from cardiovascular causes by 23%. Psaty, et al 1997 • 3 mmHg decrease in systolic BP reduces annual mortality from stroke, coronary heart diseases and all other causes by 8%, 5% and 4%. Whelton PK, 1994 •The chances of mortality from CVD in old hypertensive people when taking anti hypertensive medications is decreased by 34%. MacMahon, 1993
  • 17. 17 Economic Impact The economic burden of chronic NCDs can be analyzed on two levels. •First, the effects of macroeconomic policies on opportunities for prevention in different population groups •Second, the cost and overall efficiency of interventions must be evaluated in terms of effectiveness and health gains for the population at large.
  • 18. 18 Economic Impact Direct Cost: Including prescribing medicines, inpatient visits, outpatient visits, emergency room visits, office- based medical provider visits, home health visits, and other medical expenses Sanjeev Balu, 2001 Indirect Cost: Productivity loss ($300 per eligible employee per year) absence & short term disability Goetzel (2004), the only study in the U.S.
  • 19. 19 Economic Impact •Poor are disproportionately affected •more vulnerable •Prevalence 6 time more in uneducated •Medication cost up to US$ 100 per month •further poverty •Cost to Health Services •USA total cost of CVD is 2% of the gross domestic product • direct medical costs estimated at nearly $55.0 billion for the year 2001 Sanjeev Balu, 2001 •Canada 21% of all diseases costs are due to CVD (US$12 billion/Year) direct cost is $3,072 per person per year, and indirect cost is $854 Guijing Wang,2008
  • 20. 20 Economic Impact In Alkhobar the total direct cost of hypertension care for patients registered in the primary health care represented 6.32% of the estimated cost of treating the expected number of patients. Al-Shahri 1998
  • 21. 21 Prevention Primary prevention is the most cost-effective approach to containing the emerging hypertension epidemic. Hussein AlGezairy Regional Director for WHO
  • 22. 22 Prevention Incidence of hypertension was reduced by 20% to 50% if primary prevention were implemented Stamler 1991 For the developing countries prevention of hypertension should be the goal.
  • 23. 23 Prevention Life style Modification: •perform aerobic exercise •maintain a healthy body weight •follow a healthy diet •restrict salt intake •stress management •limit alcohol consumption
  • 24. 24 Modification Recommendation Approximate systolic BP reduction Weight reduction Maintenance of normal body weight 5–20 mmHg/10 kg healthy eating plan Consumption a diet rich in vegetables, fruits, and low-fat dairy products with a reduced content of saturated and total fat 8–14 mm Hg Dietary sodium Reduction dietary sodium intake to no more than 2.4 g sodium 2–8 mmHg Physical activity Engagement in regular aerobic physical activity at least 30 minutes daily, most days of the week 4–9mmHg Recommended lifestyle modifications
  • 25. 25 Life style Modification • Weight reduction Every 1 kilogram of weight loss lower blood pressure by 1.6/1.1 mmHg Khatib et al. EMR0 Technical Publications
  • 26. 26 Prevalence of overweight and obesity among some countries of the Eastern Mediterranean Region (WHO.2004) Country Overweight/obesity (%) Males Females Saudi Arabia 64.0 70.0 Lebanon 60.0 53.0 Islamic Republic of Iran 57.0 67.7 Bahrain 56.4 79.0 Jordan 46.0 43.7 Egypt 43.8 41.0 Libyan Arab Jamahiriya 42.5 74.9 Oman 40.5 43.5 Morocco 37.2 21.7 United Arab Emirates 25.5 39.9 Tunisia 13.1 41.9 Kuwait 79 56
  • 27. In Bahrain National Non-communicable Diseases Risk Factors Survey 2007
  • 28. In Sudan  of 6-12y children: 45 (14.8%) were overweight; 32 (10.5%) were obese Salman Z et al 2010
  • 29. 29
  • 30. 30 Life style Modification • Eating habits
  • 31. 31
  • 32. 32 Life style Modification • Physical activity Exercise lowers systolic and diastolic blood pressure by 5-10 mmHg Arakawa
  • 33. 33 Life style Modification • Physical activity National Non-communicable Diseases Risk Factors Survey 2007
  • 34. 34 Life style Modification • Sodium moderation Reducing dietary sodium intake to no more than 100 mEq/L )2.4g sodium or 6 g sodium chloride), reduces the blood pressure by an average of 4–6 mmHg. Khatib et al. EMR0 Technical Publications
  • 35. 35 Life style Modification • Diabetes (In Bahrain) National Non-communicable Diseases Risk Factors Survey 2007
  • 36. 36 Life style Modification • Diabetes (In Bahrain)
  • 37. 37 Life style Modification • Tobacco )In Bahrain) National Non-communicable Diseases Risk Factors Survey 20
  • 38. -Lipids
  • 39. 39 Life style Modification • Lipids (In Bahrain) National Non-communicable Diseases Risk Factors Survey 20
  • 40. 40 Life style Modification • Cocoa ingestion 100g/day of chocolate drink reduces the systolic BP and diastolic BP Taubert et al 2007
  • 41. 41 Blood Pressure Pooled Change (mm Hg) P Cocoa Systolic -4.7 .002 Diastolic -2.8 .006 Tea Systolic 0.4 .63 Diastolic -0.6 .38 Change in Blood Pressure reduction between cocoa & Tea Taubert et al 2007
  • 42. 42 Change in Blood Pressure reduction between cocoa & Tea Taubert et al 2007 “The magnitude of the hypotensive effects of cocoa is in the range that is usually achieved with monotherapy of β-blockers or angiotensin- converting enzyme inhibitors”
  • 43. Chocolate and Coronary Heart Disease: A Systematic Review This article reviews current evidence on the effects of cocoa/chocolate on clinical and subclinical coronary heart disease (CHD), CHD risk factors, and potential biologic mechanisms.  The high content of polyphenols and flavonoids present in cocoa has been reported to play an important protective role in the development of CHD.  Although studies have demonstrated beneficial effects of chocolate on endothelial function, blood pressure, serum lipids, insulin resistance, and platelet function, it is unclear whether chocolate consumption influences the risk of CHD. Khawaja O et al Current Atherosclerosis Reports, Volume 13 / September 2011
  • 44. 44 Measurement of Blood Pressure The "white-coat" effect Prevalence of white coat hypertension was 3.6% overall and 12.8% in hypertensive patients. Marquez Contreras et al. 2006
  • 45. 45 Measurement of Blood Pressure The "white-coat" effect Prevalence of white coat hypertension was 3.6% overall and 12.8% in hypertensive patients. Marquez Contreras et al. 2006
  • 46. 46 Measurement of Blood Pressure The "white-coat" effect Prevalence of white coat hypertension was 3.6% overall and 12.8% in hypertensive patients. Marquez Contreras et al. 2006
  • 47. 47 Hypertension Control Very poor control of hypertension world wide •In Egypt 23.9% were receiving treatment & 8% controlled Ibrahim et al. •In Canada 15.8% had blood pressure treated and controlled Petrella et al, 2007 •In Saudi Arabia, 76 % were receiving treatment, but only 20% were found controlled Abolfotouh et al,
  • 48. 48 Measurement of Blood Pressure •Seated in a quiet room •Arm muscles relaxed •Cubital fossa at heart level •Avoid tight sleeves •Suitable size Cuff to be used •Repeat if BP > 140/90 •Measurement on both arms •Mercury sphygmomanometers are most reliable Goodman and Gilman's1993
  • 49. 49 Management Good management of hypertension is central to any strategy formulated to control hypertension at the community level. Randomized trials of drugs that lower and control blood pressure clearly show a reduction in mortality and morbidity. Hussein A. Gezairy Regional Director for the Eastern Mediterranean
  • 50. 50 Management 2 mmHg reduction in systolic blood pressure is likely to reduce the annual mortality from stroke, coronary heart disease and all other causes by 6%, 4% and 3%, respectively
  • 51. 51 Conclusion Hypertension is a serious problem that could be called "the silent killer". Its prevalence is very high especially in the GCC countries. Effective efforts ought to be taken in order to prevent, prevent, prevent, prevent then diagnose and treat it.
  • 52. 52 Conclusion Hypertension is a serious problem that could be called "the silent killer". Its prevalence is very high especially in the GCC countries. Effective efforts ought to be taken in order to prevent, prevent, prevent, prevent then diagnose and treat it.
  • 53. 53 Conclusion Hypertension is a serious problem that could be called "the silent killer". Its prevalence is very high especially in the GCC countries. Effective efforts ought to be taken in order to prevent, prevent, prevent, prevent then diagnose and treat it.
  • 54. 54 Thank you
  • 55. 55